News | July 05, 2023
Syngene to acquire multi-modal facility from Stelis Biopharma
Adding 20,000 liters of installed biologics drug substance manufacturing capacity
Adding 20,000 liters of installed biologics drug substance manufacturing capacity
Cipla has a robust governance model focused on sustainability
Takes over the commercialization of Biosimilars Business from Viatris in 70+ countries
Dr. Vivek joins Healthium after a stint at Ethicon, Johnson & Johnson
The transaction represents an enterprise value of €275 million, an estimated 2023 EV/EBITDA multiple of 18x
The zero-observation outcome reflects the company's robust quality management systems and commitment to excellence in its operations.
Investment will help fuel international partnerships, grow IGX Platform functionality, and diversify proposition with new generative AI solutions
Lupin has received US$ 25 million from AbbVie for initiation of Phase 1 clinical studies successfully
Granules India sponsored an initiative to ignite a drug-free revolution and contribute towards an empowered society
New reforestation projects in Brazil, India, Vietnam, Ghana and Rwanda in addition to existing projects including in Australia and Indonesia
Subscribe To Our Newsletter & Stay Updated
